Free Trial

Brown Advisory Inc. Has $27.67 Million Position in AVANOS MEDICAL, INC. (NYSE:AVNS)

Avanos Medical logo with Medical background

Brown Advisory Inc. raised its stake in shares of AVANOS MEDICAL, INC. (NYSE:AVNS - Free Report) by 1.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,931,163 shares of the company's stock after acquiring an additional 26,069 shares during the quarter. Brown Advisory Inc. owned approximately 4.20% of AVANOS MEDICAL worth $27,674,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in AVNS. Comerica Bank increased its holdings in AVANOS MEDICAL by 3.4% during the 4th quarter. Comerica Bank now owns 22,903 shares of the company's stock valued at $365,000 after purchasing an additional 755 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of AVANOS MEDICAL by 3.6% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,834 shares of the company's stock worth $411,000 after purchasing an additional 901 shares during the last quarter. EP Wealth Advisors LLC increased its stake in shares of AVANOS MEDICAL by 14.6% in the fourth quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock valued at $161,000 after buying an additional 1,289 shares in the last quarter. Azzad Asset Management Inc. ADV raised its holdings in shares of AVANOS MEDICAL by 3.5% in the first quarter. Azzad Asset Management Inc. ADV now owns 41,039 shares of the company's stock valued at $588,000 after buying an additional 1,404 shares during the last quarter. Finally, Gotham Asset Management LLC lifted its position in AVANOS MEDICAL by 5.3% during the 4th quarter. Gotham Asset Management LLC now owns 28,234 shares of the company's stock worth $449,000 after buying an additional 1,425 shares in the last quarter. Institutional investors and hedge funds own 95.17% of the company's stock.

AVANOS MEDICAL Price Performance

Shares of AVNS traded down $0.32 during mid-day trading on Friday, hitting $11.95. 309,333 shares of the company traded hands, compared to its average volume of 385,775. The company has a current ratio of 2.57, a quick ratio of 1.56 and a debt-to-equity ratio of 0.12. The business has a 50-day moving average of $12.42 and a 200 day moving average of $14.02. AVANOS MEDICAL, INC. has a one year low of $11.68 and a one year high of $25.36. The stock has a market capitalization of $552.34 million, a price-to-earnings ratio of -1.43 and a beta of 1.12.

AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. The firm had revenue of $167.50 million for the quarter, compared to analyst estimates of $161.75 million. AVANOS MEDICAL had a positive return on equity of 6.26% and a negative net margin of 55.80%. The business's quarterly revenue was up .8% compared to the same quarter last year. During the same period last year, the company earned $0.22 EPS. As a group, equities analysts expect that AVANOS MEDICAL, INC. will post 1.32 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of AVANOS MEDICAL from a "hold" rating to a "buy" rating in a research report on Wednesday, March 19th.

Read Our Latest Stock Analysis on AVNS

About AVANOS MEDICAL

(Free Report)

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

Recommended Stories

Institutional Ownership by Quarter for AVANOS MEDICAL (NYSE:AVNS)

Should You Invest $1,000 in AVANOS MEDICAL Right Now?

Before you consider AVANOS MEDICAL, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AVANOS MEDICAL wasn't on the list.

While AVANOS MEDICAL currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines